Bionomics Limited (BNOEF) is a Biotechnology company in the Healthcare sector, currently trading at $0.01. It has a SharesGrow Score of 37/100, indicating a weak investment profile with 1 out of 7 criteria passed.
Financials: revenue is $24M, -95.8%/yr average growth. Net income is $565,773 (loss), growing at -24099%/yr. Net profit margin is -2.4% (negative). Gross margin is 95.8% (+2736.2 pp trend).
Balance sheet: total debt is $226,487 against $29M equity (Debt-to-Equity (D/E) ratio 0.01, conservative). Current ratio is 3.56 (strong liquidity). Debt-to-assets is 0.5%. Total assets: $43M.
Analyst outlook: 2 / 3 analysts rate BNOEF as buy (67%) — moderate consensus.
SharesGrow 7-Criteria breakdown: Value ?/100 (Fail), Growth 15/100 (Fail), Past 0/100 (Fail), Health 100/100 (Pass), Moat 50/100 (Partial), Future 55/100 (Partial), Income 10/100 (Fail).
